Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of Cerebral Amyloid Plaques Using PET With Fluoro Tracker for Early Diagnosis of Alzheimer's Disease

NCT01325259 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT01325259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01325259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of Cerebral Amyloid Plaques Using PET With Fluoro Tracker for Early Diagnosis of Alzheimer's Disease
Lead sponsor
University Hospital, Tours
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2009
Completion date
December 31, 2013
Enrollment
54 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, mild cognitive impairment